Literature DB >> 23576567

NF-κB regulates radioresistance mediated by β1-integrin in three-dimensional culture of breast cancer cells.

Kazi Mokim Ahmed1, Hui Zhang, Catherine C Park.   

Abstract

β1-integrin induction enhances breast cancer cell survival after exposure to ionizing radiation (IR), but the mechanisms of this effect remain unclear. Although NF-κB initiates prosurvival signaling pathways post-IR, the molecular function of NF-κB with other key elements in radioresistance, particularly with respect to extracellular matrix-induced signaling, is not known. We discovered a typical NF-κB-binding site in the β1-integrin promoter region, indicating a possible regulatory role for NF-κB. Using three-dimensional laminin-rich extracellular matrix (3D lrECM) culture, we show that NF-κB is required for β1-integrin transactivation in T4-2 breast cancer cells post-IR. Inhibition of NF-κB reduced clonogenic survival and induced apoptosis and cytostasis in formed tumor colonies. In addition, T4-2 tumors with inhibition of NF-κB activity exhibit decreased growth in athymic mice, which was further reduced by IR with downregulated β1-integrin expression. Direct interactions between β1-integrin and NF-κB p65 were induced in nonmalignant breast epithelial cells, but not in malignant cells, indicating context-specific regulation. As β1-integrin also activates NF-κB, our findings reveal a novel forward feedback pathway that could be targeted to enhance therapy. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23576567      PMCID: PMC3698967          DOI: 10.1158/0008-5472.CAN-12-3537

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  47 in total

Review 1.  Structural cues from the tissue microenvironment are essential determinants of the human mammary epithelial cell phenotype.

Authors:  K L Schmeichel; V M Weaver; M J Bissell
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

2.  Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells.

Authors:  F Aoudjit; K Vuori
Journal:  Oncogene       Date:  2001-08-16       Impact factor: 9.867

Review 3.  Nuclear factor-kappaB in cancer development and progression.

Authors:  Michael Karin
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

Review 4.  Environment-mediated drug resistance: a major contributor to minimal residual disease.

Authors:  Mark B Meads; Robert A Gatenby; William S Dalton
Journal:  Nat Rev Cancer       Date:  2009-08-20       Impact factor: 60.716

5.  Nuclear factor-kappaB p65 inhibits mitogen-activated protein kinase signaling pathway in radioresistant breast cancer cells.

Authors:  Kazi M Ahmed; Shaozhong Dong; Ming Fan; Jian Jian Li
Journal:  Mol Cancer Res       Date:  2006-12       Impact factor: 5.852

6.  Activation of nuclear factor kappaB in radioresistance of TP53-inactive human keratinocytes.

Authors:  Xufeng Chen; Binghui Shen; Liqun Xia; Alexander Khaletzkiy; David Chu; Jeffrey Y C Wong; Jian-Jian Li
Journal:  Cancer Res       Date:  2002-02-15       Impact factor: 12.701

7.  The PHSCN dendrimer as a more potent inhibitor of human breast cancer cell invasion, extravasation, and lung colony formation.

Authors:  Hongren Yao; Donna M Veine; Kevin S Fay; Evan D Staszewski; Zhao-Zhu Zeng; Donna L Livant
Journal:  Breast Cancer Res Treat       Date:  2010-03-19       Impact factor: 4.872

8.  Promyelocytic leukemia protein sensitizes tumor necrosis factor alpha-induced apoptosis by inhibiting the NF-kappaB survival pathway.

Authors:  Wen-Shu Wu; Zhi-Xiang Xu; Walter N Hittelman; Paolo Salomoni; Pier Paolo Pandolfi; Kun-Sang Chang
Journal:  J Biol Chem       Date:  2003-01-22       Impact factor: 5.157

9.  Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts.

Authors:  Catherine C Park; Hui J Zhang; Evelyn S Yao; Chong J Park; Mina J Bissell
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

10.  Inhibition of cell attachment, invasion and metastasis of human carcinoma cells by anti-integrin beta 1 subunit antibody.

Authors:  S Fujita; H Suzuki; M Kinoshita; S Hirohashi
Journal:  Jpn J Cancer Res       Date:  1992-12
View more
  37 in total

1.  Transcriptome profiling of the cancer and adjacent nontumor tissues from cervical squamous cell carcinoma patients by RNA sequencing.

Authors:  Guo Peng; Wang Dan; Wu Jun; Yang Junjun; Ren Tong; Zhu Baoli; Xiang Yang
Journal:  Tumour Biol       Date:  2015-01-14

Review 2.  Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance.

Authors:  Hassan Yousefi; Mousa Vatanmakanian; Mojdeh Mahdiannasser; Ladan Mashouri; Nikhilesh V Alahari; Mohammad Rafiee Monjezi; Shahrzad Ilbeigi; Suresh K Alahari
Journal:  Oncogene       Date:  2021-01-08       Impact factor: 9.867

3.  β1-Integrin Impacts Rad51 Stability and DNA Double-Strand Break Repair by Homologous Recombination.

Authors:  Kazi Mokim Ahmed; Raj K Pandita; Dharmendra Kumar Singh; Clayton R Hunt; Tej K Pandita
Journal:  Mol Cell Biol       Date:  2018-04-16       Impact factor: 4.272

4.  RelB Expression Determines the Differential Effects of Ascorbic Acid in Normal and Cancer Cells.

Authors:  Xiaowei Wei; Yong Xu; Fang Fang Xu; Luksana Chaiswing; David Schnell; Teresa Noel; Chi Wang; Jinfei Chen; Daret K St Clair; William H St Clair
Journal:  Cancer Res       Date:  2017-01-20       Impact factor: 12.701

5.  PTK7 regulates radioresistance through nuclear factor-kappa B in esophageal squamous cell carcinoma.

Authors:  Misun Park; Hyeon-Joon Yoon; Moon Chul Kang; Junhye Kwon; Hae Won Lee
Journal:  Tumour Biol       Date:  2016-08-24

Review 6.  Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance.

Authors:  Behrad Darvishi; Mohammad Reza Eisavand; Keivan Majidzadeh-A; Leila Farahmand
Journal:  Br J Cancer       Date:  2022-02-05       Impact factor: 9.075

Review 7.  The pro-tumorigenic host response to cancer therapies.

Authors:  Yuval Shaked
Journal:  Nat Rev Cancer       Date:  2019-10-23       Impact factor: 60.716

8.  Cell-ECM interactions control DDR.

Authors:  Ellen Dickreuter; Nils Cordes
Journal:  Oncoscience       Date:  2015-08-10

9.  Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.

Authors:  Jie Yuan; Manran Liu; Li Yang; Gang Tu; Qing Zhu; Maoshan Chen; Hong Cheng; Haojun Luo; Weijie Fu; Zhenhua Li; Guanglun Yang
Journal:  Breast Cancer Res       Date:  2015-05-21       Impact factor: 6.466

Review 10.  β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer.

Authors:  Anne-Florence Blandin; Guillaume Renner; Maxime Lehmann; Isabelle Lelong-Rebel; Sophie Martin; Monique Dontenwill
Journal:  Front Pharmacol       Date:  2015-11-24       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.